Aprea Therapeutics - 53 Year Dividend History | APRE

Historical dividend payout and yield for Aprea Therapeutics (APRE) since 1971. The current TTM dividend payout for Aprea Therapeutics (APRE) as of May 28, 2024 is $0.00. The current dividend yield for Aprea Therapeutics as of May 28, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.028B $0.001B
Aprea Therapeutics Inc. is a biopharmaceutical company. It is focused on developing and commercializing novel cancer therapeutics which reactivate the mutant tumor suppressor protein, p53. The Company's lead drug candidate, APR-246, a first-in-class small molecule p53 reactivator, is in clinical development for myelodysplastic syndromes, acute myeloid leukemia as well as additional hematologic and solid tumor malignancies. Aprea Therapeutics Inc. is based in Boston, Massachusetts.
Stock Name Country Market Cap PE Ratio